OpenAI has deployed thousands of AI agents to analyze complex biological data, aiming to accelerate the discovery of new research leads in the life sciences. The approach leverages large-scale agentic AI systems to process and interpret multi-modal biological datasets, potentially enabling faster hypothesis generation and experimental validation in drug discovery and genomics.